[Therapeutic indication of interferons for renal cell carcinoma].
Harano
Masahiko
M
Department of Urology, Graduate School of Medical Sciences, Kyushu University.
Naito
Seiji
S
D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D002453:Cell Cycle; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008262:Macrophage Activation; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D016159:Tumor Suppressor Protein p53; D007372:Interferons